← Back
$NKTR All transactions

NEKTAR THERAPEUTICS

A

$ Value

$0

Shares

21,667

Price

$0

Filed

Dec 23

Insider

Name

ROBIN HOWARD W

Title

President & CEO

CIK

0001206869

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-22

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

75,912

Footnotes

Common stock was acquired pursuant to a grant of restricted stock units ("RSU"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs vest over four years from the date of grant (December 22, 2025) in substaintially equal quarterly installments based on continued service. | Stock options vest over four years from the date of grant, (December 22, 2025) in substantially equal monthly installments based on continued service.

Filing Info

Accession No.

0001193125-25-331187

Form Type

4

Issuer CIK

0000906709

ROBIN HOWARD W's History

Date Ticker Type Value
2026-02-18 NKTR $31K
2025-12-22 NKTR A $0
2025-12-22 NKTR A $0
2025-11-25 NKTR $120K
2025-11-21 NKTR A $0
2025-11-21 NKTR A $0
2025-09-09 NKTR $95K
2025-09-09 NKTR $56K
2025-09-09 NKTR $102K
2025-09-09 NKTR $58K

Other Insiders at NKTR (90d)

Insider Bought Sold Last
ROBIN HOWARD W
President & CEO
$31K 2026-02-18
Zalevsky Jonathan
Chief R&D Officer
$13K 2026-02-18